WEBVTT

00:00.000 --> 00:03.193
There's so much exciting movement in the field of metabolic health.

00:03.193 --> 00:13.428
And a few trends that stand out to me are the expansion of GLP-1 medications beyond
obesity and diabetes into areas like inflammation, addiction, possibly even

00:13.444 --> 00:14.945
neurodegenerative change,

00:15.513 --> 00:16.312
a pipeline

00:16.345 --> 00:17.861
of next generation

00:17.861 --> 00:26.637
pharmacotherapies that may offer greater efficacy, better tolerability, and potentially
lower costs, and the growing potential of AI.

00:26.637 --> 00:35.987
and digital tools to personalize care, not just based on clinical profiles, but also on
biometric data, engagement signals, and behavioral patterns.